Acetic Acid

Acetic Acid

SCHEMBL2167465

CC(=O)O.CCS(=O)(=O)O.OCCO

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

FGFR1FGFR2FGFR3FGFR4FLT1FLT4KDRPDGFRAPDGFRB

The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
FFAR3 O14843 3/20 0.41
LCK P06239 1/20 0.41
FYN P06241 1/20 0.41
ALDH1A1 P00352 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
HDAC3 O15379 1/20 0.30
HDAC1 Q13547 1/20 0.30
HDAC2 Q92769 1/20 0.30
HDAC8 Q9BY41 1/20 0.30
POLB P06746 1/20 0.30
KDM4E B2RXH2 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL3455135 0.91 FFAR3 (0.50) FFAR3LCKFYNALDH1A1TDP1
1,4-Butanediol SCHEMBL2168624 0.89 SMN1; SMN2 (0.41) FFAR3LCKFYNALDH1A1TDP1
Ethylene Glycol SCHEMBL28390899 0.87 TSHR (0.39) ALDH1A1TDP1SMN1; SMN2
Ethylene Glycol SCHEMBL29024223 0.87 TSHR (0.39) ALDH1A1TDP1SMN1; SMN2
Acetic Acid SCHEMBL2167895 0.86 FFAR3 (0.39) FFAR3LCKFYN
Acetic Acid SCHEMBL2169185 0.85 FFAR3 (0.44) FFAR3LCKFYNALDH1A1TDP1
Acetic Acid SCHEMBL2167716 0.83 FFAR3 (0.37) FFAR3LCKFYN
Acetic Acid SCHEMBL8723843 0.82 FFAR3 (0.41) FFAR3LCKFYNALDH1A1TDP1
Acetic Acid SCHEMBL2166856 0.81 FFAR3 (0.35) FFAR3LCKFYNALDH1A1TDP1
Bicarbonate SCHEMBL28332006 0.81 FFAR3 (0.44) FFAR3LCKFYNALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8383274-B2 Nonaqueous electrolyte solution for lithium battery, lithium battery using same, and formyloxy group-containing compound used therein UBE INDUSTRIES, LTD. (JP) 2013-02-26 US disclosed
US-20110183199-A1 NONAQUEOUS ELECTROLYTE SOLUTION FOR LITHIUM BATTERY, LITHIUM BATTERY USING SAME, AND FORMYLOXY GROUP-CONTAINING COMPOUND USED THEREIN UBE INDUSTRIES, LTD. (JP) 2011-07-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110183199-A1 NONAQUEOUS ELECTROLYTE SOLUTION FOR LITHIUM BATTERY, LITHIUM BATTERY USING SAME, AND FORMYLOXY GROUP-CONTAINING COMPOUND USED THEREIN HCN2, KCNN2, KCNB1 FFAR3 996/4885LCK 455/4885FYN 481/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.